TrialThe journal of headache and pain2018

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.

Andrew M Blumenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.